At a glance
ClinicalIndex Comparison RecordN/ACompleted· 52 enrolled
Drug / intervention
Osmolite and B.C.A.A. +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Short Term Feeding for Hospitalised Asian Patients With Liver Cirrhosis - a Randomised Trial of Naso-gastric vs Oral Feeding
In Brief
A clinical study evaluating Osmolite and B.C.A.A. and Normal oral intake & supplementation if necessary for CIRRHOSIS. Completed, enrolled 52 participants across 1 site.
Detailed Summary
The benefits of short-term naso-gastric feeding in patients with advanced cirrhosis remain uncertain. This was a randomised study comparing naso-gastric feeding and oral feeding in Asian patients with cirrhosis who were admitted to hospital for decompensation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCIRRHOSIS
CountriesMalaysia
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2008
Primary CompletionMay 2009
Study CompletionMay 2010
First PostedJul 2010
TodayJul 2026
First PostedJul 19, 2010
Enrollment StartMar 1, 2008
Primary CompletionMay 1, 2009
Study CompletionMay 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 16.0 years ago
Interventions
Osmolite and B.C.A.A.dietary
Feeding inserted into enteral tubes
Normal oral intake & supplementation if necessarydietary
Enteral nutrition